ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,302Medicare Part D Prescriptions Filled, Including Refills

Rank: 152 out of 944

$376K Total Retail Price of All Prescriptions

Rank: 375 out of 944

338 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 338 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,635 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 805 737 1 1
LEVOTHYROXINE SODIUM 561 510 2 2
LISINOPRIL 521 496 3 3
AMLODIPINE BESYLATE 384 378 4 5
WARFARIN SODIUM 358 358 5 7
METOPROLOL SUCCINATE 344 313 6 14
LOSARTAN POTASSIUM 324 308 7 16
ATENOLOL 318 305 8 11
OMEPRAZOLE 288 243 9 4
METOPROLOL TARTRATE 281 268 10 8
FUROSEMIDE 268 268 11 6
HYDROCHLOROTHIAZIDE 266 263 12 9
HYDROCODONE-ACETAMINOPHEN 228 205 S3 13 10
POTASSIUM CHLORIDE 181 172 14 15
CITALOPRAM HBR 175 164 15 19
SERTRALINE HCL 175 151 15 23
GLIMEPIRIDE 174 172 17 47
CRESTOR 163 154 18 28
TRAMADOL HCL 150 149 19 21
METFORMIN HCL 134 126 20 12
ALENDRONATE SODIUM 127 127 21 20
ATORVASTATIN CALCIUM 114 109 22 13
GABAPENTIN 111 111 23 18
TRIAMTERENE-HCTZ 100 98 24 33
MIRTAZAPINE 94 94 25 35
ISOSORBIDE MONONITRATE ER 91 91 26 52
DILTIAZEM ER 83 83 27 88
PRAVASTATIN SODIUM 83 83 27 17
ZOLPIDEM TARTRATE 82 82 29 25
DONEPEZIL HCL 81 81 30 24
ALLOPURINOL 81 81 30 22
FLUOXETINE HCL 75 49 32 48
LANTUS 71 71 33 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 63 34 29
LIDODERM 67 49 35 73
TRAZODONE HCL 64 63 36 45
PANTOPRAZOLE SODIUM 63 51 37 34
LOSARTAN-HYDROCHLOROTHIAZIDE 62 51 38 54
OXYBUTYNIN CHLORIDE 59 47 39 94
FENTANYL 55 55 S2 40 57
FLUTICASONE PROPIONATE 54 45 41 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.